Arrowhead Pharmaceuticals, Inc.ARWRNASDAQ
Loading
Interest Expense Over TimeStrong
Percentile Rank100
3Y CAGR+70.1%
Studio
Year-over-Year Change

Interest expense on outstanding debt

3Y CAGR
+70.1%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
4.9x
Strong expansion
Streak
4 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$90.22M+1.0%
2025$89.36M+176.2%
2024$32.35M+76.5%
2023$18.33M-
2022$0.00-
2021$0.00-
2020$0.00-
2019$0.00-
2018$0.00-
2017$0.00-